Zhang L - Search Results

1

A ²¹¹At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy.

Xie L, Zhang L, Hu K, Hanyu M, Zhang Y, Fujinaga M, Minegishi K, Ohkubo T, Nagatsu K, Jiang C, Shimokawa T, Ashisuke K, Okonogi N, Yamada S, Wang F, Wang R, Zhang MR. Xie L, et al. Among authors: zhang l, zhang mr, zhang y. Cell Rep Med. 2023 Apr 18;4(4):100960. doi: 10.1016/j.xcrm.2023.100960. Epub 2023 Mar 31. Cell Rep Med. 2023. PMID: 37003259 Free PMC article.

2

[⁶⁸Ga]Ga-NOTA-MAL-Cys³⁹-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma.

Zhang P, Zhao Z, Zhang L, Wu W, Xu Y, Pan D, Wang F, Yang M. Zhang P, et al. Among authors: zhang l. Nucl Med Biol. 2019 Jul-Aug;74-75:19-24. doi: 10.1016/j.nucmedbio.2019.08.002. Epub 2019 Aug 16. Nucl Med Biol. 2019. PMID: 31450071

3

Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy.

Xie L, Hu K, Duo Y, Shimokawa T, Kumata K, Zhang Y, Jiang C, Zhang L, Nengaki N, Wakizaka H, Cao Y, Zhang MR. Xie L, et al. Among authors: zhang l, zhang mr, zhang y. J Immunother Cancer. 2021 Jun;9(6):e002616. doi: 10.1136/jitc-2021-002616. J Immunother Cancer. 2021. PMID: 34148865 Free PMC article.

4

²¹¹At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer.

Shi X, Li Q, Zhang L, Hanyu M, Xie L, Hu K, Nagatsu K, Zhang C, Wu Z, Wang F, Zhang MR, Yang K, Zhu R. Shi X, et al. Among authors: zhang l, zhang mr, zhang c. Bioconjug Chem. 2021 Aug 18;32(8):1763-1772. doi: 10.1021/acs.bioconjchem.1c00263. Epub 2021 Jul 14. Bioconjug Chem. 2021. PMID: 34260853

5

Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells.

Hu K, Ma X, Xie L, Zhang Y, Hanyu M, Obata H, Zhang L, Nagatsu K, Suzuki H, Shi R, Wang W, Zhang MR. Hu K, et al. Among authors: zhang l, zhang mr, zhang y. ACS Omega. 2021 Dec 22;7(1):334-341. doi: 10.1021/acsomega.1c04711. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036703 Free PMC article.

6

Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.

Hu K, Wu W, Xie L, Geng H, Zhang Y, Hanyu M, Zhang L, Liu Y, Nagatsu K, Suzuki H, Guo J, Wu Y, Li Z, Wang F, Zhang M. Hu K, et al. Among authors: zhang l, zhang m, zhang y. Acta Pharm Sin B. 2022 Mar;12(3):1363-1376. doi: 10.1016/j.apsb.2021.09.016. Epub 2021 Sep 22. Acta Pharm Sin B. 2022. PMID: 35530129 Free PMC article.

7

PEIGel: A biocompatible and injectable scaffold with innate immune adjuvanticity for synergized local immunotherapy.

Xiao Z, Wang D, Wang C, Chen Z, Huang C, Yang Y, Xie L, Zhang L, Xu L, Zhang MR, Hu K, Li Z, Luo L. Xiao Z, et al. Among authors: zhang l, zhang mr. Mater Today Bio. 2022 May 18;15:100297. doi: 10.1016/j.mtbio.2022.100297. eCollection 2022 Jun. Mater Today Bio. 2022. PMID: 35637855 Free PMC article.

8

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression.

Zhang L, Zhang S, Wu W, Wang X, Shen J, Wang D, Hu K, Zhang MR, Wang F, Wang R. Zhang L, et al. Among authors: zhang mr, zhang s. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/65047. J Vis Exp. 2023. PMID: 36806629

9

Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors.

Zhang L, Zhang S, Wu J, Wang Y, Wu Y, Sun X, Wang X, Shen J, Xie L, Zhang Y, Zhang H, Hu K, Wang F, Wang R, Zhang MR. Zhang L, et al. Among authors: zhang mr, zhang s, zhang h, zhang y. Mol Pharm. 2023 Aug 7;20(8):4256-4267. doi: 10.1021/acs.molpharmaceut.3c00382. Epub 2023 Jun 27. Mol Pharm. 2023. PMID: 37368947

10

¹⁷⁷Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians.

Bu T, Zhang L, Yu F, Yao X, Wu W, Zhang P, Shi L, Zang S, Meng Q, Ni Y, Shao G, Qiu X, Ai S, Jia R, Guo H, Wang F. Bu T, et al. Among authors: zhang l, zhang p. Front Oncol. 2022 Mar 24;12:835956. doi: 10.3389/fonc.2022.835956. eCollection 2022. Front Oncol. 2022. PMID: 35402274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124,724 results

Search Page